Glaucoma can quietly damage vision long before symptoms appear. Learn how early detection, advanced imaging, and personalized care can help preserve sight and transform glaucoma from a silent threat into a manageable condition.

If you have Thyroid Eye Disease (TED), you may notice more irritation, swelling, or dryness during cold or flu season. TED is an autoimmune condition where your immune system attacks tissues around the eyes, causing inflammation, bulging, and surface symptoms like dryness or grittiness. Even after the active phase of TED seems over, flares can happen. Viral infections trigger immune responses that can inflame the ocular surface, destabilize your tear film, and worsen dryness

Early vision changes are easy to ignore, but they may be warning signs of underlying retinal disease. Your retina—the delicate, light-sensitive tissue responsible for forming the images you see—can develop silent problems long before symptoms appear. In this educational guide, Dr. Keshav Narain, board-certified ophthalmologist and founder of South Bay Retina, explains why early detection is essential and how conditions like diabetic retinopathy, age-related macular degenerati

Many people worry their cataract has “come back” after surgery, but cataracts don’t actually return. Instead, a common condition called posterior capsule opacification (PCO) can cause cloudy or blurry vision months or years later. This “secondary cataract” occurs when cells on the lens capsule become hazy—but the good news is it’s easily treatable with a quick, painless YAG laser procedure. Learn why vision can blur again after cataract surgery and how PCO is safely corrected

Normal eye pressure doesn’t always mean healthy eyes. Learn how Normal-Tension Glaucoma damages vision even with normal readings—and how to protect your sight.

San Jose | Nicotinamide, a form of vitamin B3, is emerging as a promising supplement for glaucoma. While it doesn’t lower eye pressure, research suggests it may protect the optic nerve by boosting cellular energy and supporting retinal ganglion cells. Early studies show safety and potential benefits, but larger clinical trials are still underway. Could this be the future of glaucoma care?

Wondering if Ozempic or Wegovy could harm your eyes? The truth may surprise you. While early concerns linked GLP-1 medications to rare vision problems, new research shows they may actually lower the risk of glaucoma and protect long-term eye health. Learn the early signs of glaucoma, what symptoms to watch for, and how regular eye exams can safeguard your vision.

Traditional glaucoma diagnosis often comes too late. Many cases occur with normal eye pressure, making them easy to miss. Now, advanced tests like VEP and ERG can detect early optic nerve dysfunction—before permanent damage sets in. This shift marks a new era in eye care: from reacting to damage to preventing it altogether.

In Optic Nerve and Glaucoma: Time for a Paradigm Shift, Dr. Keshav Narain challenges the long-held belief that intraocular pressure (IOP) is the sole culprit in glaucoma. Drawing from decades of clinical insight and emerging technologies like electrophysiology and microperimetry, this piece highlights a critical evolution in how we diagnose and manage the disease. With tools like Visually Evoked Potentials (VEP) and Selective Laser Trabeculoplasty (SLT), clinicians are now fo

Illustration of the human eye showing the retina, optic nerve, and macula, with highlighted areas of retinal ganglion cell loss in glaucoma and photoreceptor degeneration in macular degeneration. Arrows indicate neuroprotective strategies like neurotrophic factors, medications, and electrical stimulation targeting these retinal layers.

Selective Laser Trabeculoplasty (SLT) was first developed in the late 1990s by Dr. Mark Latina and Dr. Park as a novel approach to lowering eye pressure in glaucoma patients. Originally introduced as a second-line treatment to eye drops, SLT has evolved into a preferred first-line therapy for many types of open-angle glaucoma.